Sterling Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$14.3M Hold
351,788
0.14% 151
2019
Q2
$16.9M Hold
351,788
0.16% 136
2019
Q1
$22M Sell
351,788
-95,000
-21% -$6.53M 0.22% 127
2018
Q4
$26.7M Sell
446,788
-110,000
-20% -$6.6M 0.29% 107
2018
Q3
$35.9M Hold
556,788
0.32% 101
2018
Q2
$25.1M Buy
556,788
+35,000
+7% +$1.4M 0.23% 125
2018
Q1
$16.2M Buy
521,788
+90,000
+21% +$2.96M 0.15% 151
2017
Q4
$12.9M Buy
+431,788
New +$12.5M 0.12% 171

Other funds holding BEAT

Sterling Capital Management's BEAT Position: Q3 2019 in Review

Sterling Capital Management held its BioTelemetry, Inc. (BEAT) position steady in Q3 2019 at 351,788 shares worth $14.3M. The position accounts for 0.14% of the portfolio, ranked #151.

Sterling Capital Management first reported a position in BEAT in Q4 2017 and has held it in 8 quarters since. The position peaked at $35.9M in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Sterling Capital Management held 351,788 shares of BioTelemetry, Inc. worth $14.3M as of Q3 2019.
  • Sterling Capital Management left its BioTelemetry, Inc. share count unchanged in Q3 2019.
  • BioTelemetry, Inc. made up 0.14% of Sterling Capital Management's portfolio in Q3 2019, its #151 holding.
  • Sterling Capital Management first reported a position in BioTelemetry, Inc. in Q4 2017 and has held it in 8 quarters since.
  • Sterling Capital Management's BioTelemetry, Inc. position peaked at $35.9M in Q3 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Sterling Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.